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Low prevalence of hypertension 
with pharmacological 
treatments and associated 
factors
Baixa prevalência de hipertensão 
com tratamento farmacológico e 
fatores associados
ABSTRACT
OBJECTIVE: To assess the determinants of the lack of pharmacological 
treatment for hypertension.
METHODS: In 2005, 3,323 Mozambicans aged 25-64 years old were evaluated. 
Blood pressure, weight, height and smoking status were assessed following the 
Stepwise Approach to Chronic Disease Risk Factor Surveillance. Hypertensives 
(systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 
mmHg and/or antihypertensive drug therapy) were evaluated for awareness 
of their condition, pharmacological and non-pharmacological management, 
as well as use of herbal or traditional remedies. Prevalence ratios (PR) were 
calculated, adjusted for sociodemographic characteristics, cardiovascular risk 
factors and non-pharmacological treatment.
RESULTS: Most of the hypertensive subjects (92.3%), and nearly half of 
those aware of their condition were not treated pharmacologically. Among the 
aware, the prevalence of untreated hypertension was higher in men [PR = 1.61; 
95% confi dence interval (95%CI 1.10;2.36)] and was lower in subjects under 
non-pharmacological treatment (PR = 0.58; 95%CI 0.42;0.79); there was no 
signifi cant association with traditional treatments (PR = 0.75; 95%CI 0.44;1.26).
CONCLUSIONS: The lack of pharmacological treatment for hypertension 
was more frequent in men, and was not infl uenced by the presence of other 
cardiovascular risk factors; it could not be explained by the use of alternative 
treatments as herbal/traditional medicines or non-pharmacological management. 
It is important to understand the reasons behind the lack of management of 
diagnosed hypertension and to implement appropriate corrective actions to 
reduce the gap in the access to healthcare between developed and developing 
countries.
DESCRIPTORS: Hypertension, drug therapy. Antihypertensive Agents, 
therapeutic use. Medication Adherence. Patient Dropouts. Treatment 
Refusal. Complementary Therapies, utilization.
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Cardiovascular diseases are a growing public health chal-
lenge in low-income countries, namely in Sub-Saharan 
Africa. The increasing frequency of risk factors such as 
hypertension, obesity, diabetes or smoking and the ageing 
of the populations are key elements in the undergoing 
epidemiologic transition.20,25 Cardiovascular diseases are 
the leading cause of death worldwide, contributing to a 
third of all deaths, most of which in developing countries.2 
A systematic review showed that there were no signifi cant 
differences in the awareness, treatment and control of 
hypertension between developed and developing coun-
tries.17 Specifi cally in Mozambique, in 2007 the “diseases 
of the cardiovascular system” had a sizeable impact on 
RESUMO
OBJETIVO: Analisar os determinantes da falta de tratamento farmacológico 
da hipertensão.
MÉTODOS: Foram avaliados 3.323 moçambicanos de 25 a 64 anos em 2005. 
A pressão arterial, peso, altura e tabagismo foram avaliados segundo o estudo 
Stepwise Approach to Chronic Disease Risk Factor Surveillance. Os hipertensos 
(pressão arterial sistólica ≥ 140 mmHg e/ou pressão arterial diastólica ≥ 90 
mmHg e/ou terapia anti-hipertensiva) foram avaliados para verifi car se eram 
conscientes de sua hipertensão, se recebiam tratamento farmacológico ou não 
farmacológico e se usavam ervas ou remédios tradicionais. Foram calculadas 
as razões de prevalência (PR) para hipertensão não tratada, ajustadas para 
características sociodemográfi cas, fatores de risco cardiovascular e tratamento 
não farmacológico.
RESULTADOS: A maioria dos hipertensos (92,3%) e quase metade dos 
conscientes de sua hipertensão não eram tratados com fármacos. Entre os que 
sabiam ser hipertensos, a hipertensão sem tratamento era mais frequente em 
homens (PR = 1,61; IC95% 0,56;1,43) e não podia ser explicada pelo uso 
de tratamento não farmacológico (PR = 0,58; IC95% 0,42;0,79); não havia 
associação signifi cativa com os tratamentos tradicionais (PR = 0,75; IC95% 
0,44;1,26).
CONCLUSÕES: A falta de tratamento farmacológico da hipertensão, mais 
frequente em homens, não se explica por outros fatores de risco cardiovascular, 
nem pelo uso de tratamentos tradicionais ou tratamento não farmacológico. 
É importante entender as razões da falta de tratamento da hipertensão 
diagnosticada e implementar medidas corretivas apropriadas, para reduzir 
as diferenças no acesso a cuidados de saúde entre as populações dos países 
desenvolvidos e emergentes.
DESCRITORES: Hipertensão, quimioterapia. Anti-Hipertensivos, uso 
terapêutico. Adesão à Medicação. Pacientes Desistentes do Tratamento. 
Recusa do Paciente ao Tratamento. Terapias Complementares, utilização.
INTRODUÇÃO
the overall burden of death: approximately 15% of all 
deaths in subjects aged over 49 years.a We have previously 
shown a high prevalence of hypertension, along with low 
awareness and pharmacological treatment.1
The awareness of hypertension and the presence of 
concomitant cardiovascular risk factors (age, sex, 
overweight/obesity, smoking) are important determinants 
of the treatment and control of hypertension.17 However, 
this has seldom been addressed in sub-Saharan Africa. 
The cultural specifi cities may contribute for the frequent 
use of traditional medicine, as well as the lack of fi nancial 
resources, might have an impact on the management 
of hypertension in this region.17,20,26,b The identifi cation 
a Loureiro J, Gaspar M, Levene V. Mortalidade em Moçambique - Inquérito nacional sobre causas de mortalidade, 2007/8. Moçambique: 
Instituto Nacional de Estatística; 2009.
b World Health Organization. Traditional Medicine. Geneva; 2008 [cited 2012 Jan 25]. [Fact sheet, 134]. Available from: http://www.who.int/
mediacentre/factsheets/fs134/en/#
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of cost-effective solutions for the management of 
hypertension is a World Health Organization (WHO) 
priority.14,24 Understanding the determinants of 
non-pharmacologically treated hypertension in this 
setting may contribute to identifying locale-specifi c 
barriers to hypertension control, as well as population 
groups to be targeted by hypertension awareness-raising 
and control-promoting interventions. Therefore, we 
extended our previous analyses on the prevalence, aware-
ness and treatment of hypertension in a representative 
sample of Mozambican adults.1 This study aimed to 
assess the determinants of lack of pharmacological treat-
ment of hypertension. We considered the potential effect 
of traditional or non-pharmacological treatments, as 
well as the presence of other cardiovascular risk factors.
METHODS
This study was based on a national cross-sectional 
study conducted in Mozambique between September 
and November 2005.1 A representative sample of 
adults aged 25 to 64 years old was assembled through 
a complex multistage sampling procedure. Ninety-fi ve 
geographical clusters were selected across the country; 
all the households from each cluster were listed and 25 
randomly selected and visited.
The number of geographical clusters and the number 
of households per cluster were defi ned aiming to select 
approximately 2,800 participants, ensuring the sample 
representativeness at a national level and considering 
the expected number of eligible subjects per household 
according to the population estimates for the study 
period.c There was no substitution of the households in 
which no one answered the door and the inquirers were 
instructed to make several attempts to contact members 
of the selected households at different times and on 
different days to minimize selection bias. All eligible 
subjects in the same household (3,378) were invited to 
take part in this investigation. Fifty-fi ve subjects refused 
and 3,323 participated in the study.
The participants were evaluated following the WHO 
STEPwise approach to chronic disease risk factor 
surveillance (STEPS),d using standardized methods. 
Trained interviewers conducted face-to-face inter-
views and physical measurements in each household, 
according to a Portuguese version of the WHO STEPS 
instrument for non-communicable disease risk factors 
(core and expanded version 2.1).d
Blood pressure was measured on a single occasion by 
non-physician trained interviewers using a semiau-
tomatic sphygmomanometer (OMRON 3™) with 
appropriate cuff size. After a 5-minute rest, blood 
pressure was measured twice, one minute apart, and 
a third measurement was performed if the difference 
between the fi rst two was > 10 mmHg for systolic or 
diastolic blood pressures. We used the mean of the two 
measurements or the mean of the last two when three 
measurements were done for analysis.
Arterial hypertension was defined as systolic 
blood pressure ≥ 140 mmHg and/or diastolic blood 
pressure ≥ 90 mmHg and/or taking antihypertensive 
drug therapy in the previous two weeks. Hypertensive 
subjects were classifi ed as aware of their status when 
they reported having been told by a health professional 
in the previous 12 months that they had hypertension/
high blood pressure, or when reporting a pharmaco-
logical or non-pharmacological treatment for hyper-
tension. Participants answering affirmatively to a 
close-ended question on the use of antihypertensive 
medication in the previous two weeks were classifi ed 
as treated pharmacologically for hypertension.
Non-pharmacological management of hypertension 
was assessed by asking participants if they were 
advised to change diet, to do exercise, lose weight, or 
quit smoking due to hypertension, by indication of a 
health professional.
A close-ended question was used to assess the current 
use of any herbal or traditional remedy for the mana-
gement of raised blood pressure.
Anthropometric measurements were obtained with the 
participants wearing light clothing and no footwear. Body 
weight was measured to the nearest 0.1 kg using a digital 
scale, and height to the nearest 0.1 cm in the standing 
position using a portable stadiometer. Body mass index 
(BMI) was calculated as weight (kg) divided by squared 
height (m2), and divided into the categories defi ned by the 
WHO24 < 25.0 kg/m2, 25.0 to 29.9 kg/m2 and ≥ 30 kg/m2.
Participants were classifi ed as ever having smoked 
(current or previous smokers) and non-smokers.
The classifi cation of the place of residence as urban 
(in any of the 23 cities and 68 towns) or rural (outside 
cities or towns), and the defi nition of categories for 
the highest level of education attained were done in 
accordance with the 1997 census.
We considered the 1,140 subjects classifi ed as hyper-
tensive (weighted prevalence: 33.1%), of which 218 
were aware of their condition (weighted prevalence: 
15.1% among the hypertensive). The analyses were 
conducted considering the sampling weights and 
c Cubula B. Metodologia de estimação para os resultados do inquérito de avaliação dos factores de risco para as doenças cardiovasculares, 
STEPS (OMS). Moçambique: Instituto Nacional de Estatística: 2005.
d World Health Organization. STEPS manual. World Health Organization; 2011 [cited 2011 Mar 29]. Available from: http://www.who.int/chp/
steps/manual/en/index.html
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adjusting for strata and clustering at primary sampling 
unit level using Stata, version 11.1.
The prevalence of untreated hypertension (among 
hypertensive subjects and those aware of their 
hypertension) was estimated with the corresponding 
95% confi dence intervals (95%CI). The association 
between gender, education, place of residence, non-
-pharmacological treatment, use of herbal/traditional 
medicines and two major cardiovascular risk factors 
(overweight/obesity and smoking) and lack of treat-
ment of hypertension was quantifi ed through mutually 
adjusted prevalence ratios (PR) with 95%CI, computed 
using Poisson regression.12
The study protocol was approved by the National 
Mozambican Ethics Committee (Populacional 
study of risk factors  of cardiovascular diseases, 
Mocambique, 2005) and written informed consent 
was obtained from all participants.
RESULTS
Women represented 53.9% of the sample, nearly half the 
participants were aged below 45 years old and 21.8% 
between 55 and 64 years old. Approximately 1/3 had no 
formal education and the population was predominantly 
rural (61.0%). The overall weighted prevalence of 
obesity and ever having smoked was 8.2% and 18.3%, 
respectively. A higher percentage of women (67.6%), 
20.8% had no formal education and most subjects 
(64.7%) lived in urban areas among the hypertensive 
subjects that were aware of their condition. Obesity was 
nearly twice as frequent in this group and smoking more 
than three times less prevalent (Table 1).
Most of the hypertensive subjects (92.3%) and nearly 
half of the aware were not treated pharmacologically 
for their condition (Figure).
The results from a model including gender, education, 
place of residence, non-pharmacological treatment, 
use of herbal/traditional medicines, overweight/
Table 1. Characteristics of the study sample.
Hypertensive subjects (N = 1,140)
Hypertensive subjects aware of their 
condition (N = 218)
Variable n Unweighted (%)a Weighted (%)a n Unweighted (%)a Weighted (%)a
Gender
Women 636 55.8 53.9 153 70.2 67.6
Men 504 44.2 46.1 65 29.8 32.4
Age (years)
25 to 34 271 23.8 24.6 25 11.5 10.9
35 to 44 303 26.6 26.2 60 27.5 29.9
45 to 54 329 28.9 27.5 83 38.1 37.3
55 to 64 237 20.8 21.8 50 22.9 21.9
Education (years)b
None 342 30.1 34.4 42 19.4 20.8
1 to 4 398 35.0 35.6 79 36.6 37.2
5 161 14.2 13.1 31 14.4 18.4
6 to 7 120 10.6 9.0 25 11.6 11.0
 8 116 10.2 7.8 39 18.1 12.6
Place of residence
Rural 489 42.9 61.0 53 24.3 35.3
Urban 651 57.1 39.0 165 75.7 64.7
Body mass index (kg/m2)b
< 25.0 785 69.8 74.0 103 48.1 45.8
25.0 to-29.9 207 18.4 17.8 63 29.4 37.5
 30.0 133 11.8 8.2 48 22.4 16.6
Ever smoked
No 955 83.8 81.7 204 93.6 94.8
Yes 185 16.2 18.3 14 6.4 5.2
a Within each variable the sum of the proportions may not be 100% due to rounding off.
b The sum of the number of participants in each category may be lower than the total because of missing data.
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obesity and smoking showed that lack of pharmaco-
logical treatment for hypertension was signifi cantly 
more frequent among men (adjusted PR = 1.05, 95%CI 
1.01;1.09) and less frequent among the subjects under 
non-pharmacological (adjusted PR = 0.46, 95%CI 
0.36;0.59) or traditional (adjusted PR = 0.68, 95%CI 
0.47;1.00) treatments. Among the hypertensive 
subjects aware of their condition, being male was 
more strongly associated with lack of pharmacological 
treatment (adjusted PR = 1.61; 95%CI 0.56;1.43) and 
the inverse relation between non-pharmacological and 
pharmacological treatments remained statistically 
signifi cant (adjusted PR= 0.58; 95%CI 0.42;0.79). No 
other sociodemographic characteristics (age, educa-
tion, place of residence) or cardiovascular risk factors 
(obesity, smoking) could explain the high prevalence 
of untreated hypertension in the population (Table 2).
DISCUSSION
The high prevalence of untreated hypertension observed 
in Mozambique is largely explained by the lack of 
diagnosis, since 15% of the hypertensive subjects were 
aware of their condition. Half of the diagnosed hyper-
tensives were receiving pharmacological treatment for 
hypertension. Among the aware, under treatment with 
anti-hypertensive drugs was more frequent among men. 
Neither the use of herbal/traditional medicines nor the 
preference for non-pharmacological management of 
hypertension could explain the lack of treatment in 
this population.
The less frequent treatment of hypertension among 
men is in accordance with previous observations in 
other populations.4,11,17 This could be attributed to the 
fact that women have contact with healthcare systems 
more frequently due to maternal and child health 
programs and tend to use more medication in general.8 
Our hypothesis is that the gender differences were more 
pronounced among the aware due to a lower adherence 
to, or persistence of, the pharmacological treatment 
among men. The evaluation of the differences in adhe-
rence and compliance to treatment between genders in 
this population would allow us to test this hypothesis 
and strengthen our study. The antihypertensive drugs 
most commonly used in this setting, central acting 
methyldopa and reserpine, are associated with severe 
side effects, mainly among men.19 Diuretics and beta 
blockers are used less frequently, especially in the rural 
regions, and are also associated with erectile dysfunc-
tion.19 Angiotensin-converting enzyme inhibitors are 
not affordable for this region of limited resources, and 
these are not easily accessible through the public sector, 
in addition to the fact that they are less effective in the 
black hypertensive population.10
The presence of risk factors for cardiovascular dise-
ases could account for an increased awareness of the 
overall cardiovascular risk and to a higher frequency 
of treatment of hypertension.19 The distribution of 
many cardiovascular risk factors and the awareness of 
illnesses are dependent on sociodemographic charac-
teristics, namely in Mozambique.1,9,21
Although in other epidemiological studies blood pres-
sure levels among current smokers were similar or 
lower than those observed in non-smokers,6 the former 
tend to use health care systems less often and to have 
unhealthier habits which may account for our results.16 
Unlike those observed in our study, overweight and 
obese subjects are more likely to be aware of their 
hypertension, although it is less likely to be controlled 
because a more aggressive treatment is needed to 
overcome their higher peripheral resistance and attain 
control of the hypertension.7,18,23
Due to the scarcity of resources in this setting, we 
expect a frequent use of non-pharmacological or 
traditional treatments, especially among hypertensive 
Figure. Prevalence, awareness and untreated hypertension (among all hypertensive and among those aware of their hypertensive 
status) in the population aged 25 to 64 years old in Mozambique.
Aware
95%CI 10.8;19.4
Hypertensive
95%CI 28.2;38.0
Untreated hypertensive
(among all hypertensive)
92.3%, 95%CI 89.9;94.7
Untreated hypertensive
(among all aware)
49.1%, 95%CI 40.1;58.2
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subjects not receiving pharmacological treatment. In 
other resource poor settings, the use of complementary 
and alternative medicines was observed in up to 30% 
of the hypertensive population.11,13,15 In our study, the 
non-pharmacological approaches to the management 
of hypertension and the use of herbal/traditional 
remedies were observed mainly among those also 
treated pharmacologically. A large proportion of the 
hypertensive subjects are not receiving any support 
for the management of hypertension, even among the 
aware of their condition.
The trend towards urbanization, population ageing 
and acquisition of obesogenic lifestyles observed in 
low income countries14 contributes to an increasing 
burden of chronic diseases in these settings. This 
requires preventive measures, namely through reducing 
excessive salt intake,3 but provision of equal access to 
appropriate management of medical conditions, such 
as hypertension, is needed. Supplying the primary heal-
thcare units with basic equipment such as a calibrated 
and functioning sphygmomanometer may contribute to 
a higher proportion of the population having their blood 
pressure measured3 and a consequent improvement in 
the awareness of hypertension. Ensuring that essential 
drugs for the effective treatment of hypertension are 
made available, through a continuous supply of medi-
cine with appropriate quality control and at affordable 
prices,3 is expected to result in a higher proportion of 
treated hypertensives, as well as in better adherence to 
the treatments. Both the health-care workers and the 
general population need to be aware of the importance 
of an asymptomatic disease such as hypertension,3 
and awareness raising campaigns may contribute to 
Table 2. Prevalence ratio of untreated hypertension among the hypertensive population and among those aware of their 
hypertensive status.
Variable
Untreated hypertension (pharmacologically)
Among the hypertensive
Among the aware of their 
hypertensive status
%
Prevalence ratio
(95%CI)a
%
Prevalence ratio
(95%CI)a
Gender
Women 88.8 1 40.7 1
Men 96.5 1.05 (1.01;1.09) 66.7 1.61 (1.10;2.36)
Age (years)
25 to 44 94.1
11.00 (0.97;1.03)
51.7 1
45 to 64 90.4 47.3 1.10 (0.79;1.52)
Education (years)
0 to 4 93.4 1 46.9 1
5 to 7 91.0 1.03 (0.99;1.07) 54.7 1.29 (0.94;1.77)
 8 87.8 1.01 (0.96;1.07) 49.8 1.11 (0.76;1.62)
Place of residence
Rural 96.0 1 53.9 1
Urban 86.6 0.97 (0.92;1.02) 46.5 0.90 (0.56;1.43)
Body mass index (kg/m2)
< 25.0 95.2 1 48.2 1
25.0 to 29.9 86.0 1.02 (0.96;1.09) 55.9 1.18 (0.76;1.83)
 30 82.8 1.01 (0.94;1.07) 43.3 1.08 (0.66;1.75)
Ever smoked
No 90.8 1 47.8 1
Yes 98.9 1.01 (0.99;1.03) 73.6 1.24 (0.83;1.84)
Non-pharmacological treatment
No 98.4 1 65.3 1
Yes 42.9 0.46 (0.36;0.59) 42.9 0.58 (0.42;0.79)
Use of herbal/traditional medicines
No 93.0 1 49.7 1
Yes 43.6 0.68 (0.47;1.00) 43.6 0.75 (0.44;1.26)
a Prevalence ratios are adjusted for all the variables presented in the table.
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this. The continuous monitoring of the management 
is necessary and future health surveys conducted in 
Mozambique should allow the assessment of the deter-
minants of awareness and treatment of hypertension, 
considered within a basis of management of the global 
cardiovascular risk.24
This study provides valuable information to understand 
unmet needs in the management of hypertension in 
this setting, but some limitations need to be discussed.
The measurement of blood pressure on a single occa-
sion contributes to an overestimation of blood pressure 
and prevalence of hypertension and to an underestima-
tion of awareness.18 Participants were considered aware 
of their status if they had been told in the previous 
year that they were hypertensive, which contributes 
to underestimating the life prevalence of awareness. 
However, this does not compromise the estimates of 
treatment among the aware.
Regarding pharmacological treatment, its assessment 
considering the use of antihypertensive medication in 
the previous two weeks contributes to an underesti-
mation of treatment prevalence, by refl ecting essen-
tially the persistence of treatment. This explains the 
lower prevalence in the present study in comparison 
with other reports defi ning treatment as a previous 
prescription of anti-hypertensive drugs, regardless 
of current use. The prevalence of treatment was 
below the average of developed and developing 
countries worldwide, but it was higher than in other 
African studies relying on the STEPS methodo-
logy.7,5,17,22 According to the STEPS protocol, the use 
of antihypertensive medication was assessed without 
specifying the drugs that have a blood pressure lowe-
ring effect and other classes of drugs (e.g., anxiolytics) 
which may have been considered antihypertensive by 
the participants, contributing to an overestimation of 
the use of antihypertensive therapy.
Sample size limitations precluded the computation of 
robust sex- and place of residence-stratifi ed estimates, 
which would contribute to a deeper understanding of 
the determinants of untreated hypertension. However, 
smoking habits and obesity were not associated with 
pharmacological treatment in this population, despite 
being two important and easy to measure risk factors that 
could be expected to infl uence the awareness of hyper-
tension or the decision to treat it pharmacologically.2
In conclusion, the lack of pharmacological treatment 
of hypertension was more frequent in men, was not 
infl uenced by other cardiovascular risk factors, and 
could not be explained by the use of alternative treat-
ments as herbal/traditional medicines or non-pharmaco-
logical management. The sub-treatment of hypertension 
is a major public health issue in Mozambique and 
the setting up of hypertension control programs may 
contribute to sizable improvements in the health status 
of the population.
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